AI Verdict
RUN has stronger fundamentals based on our AI analysis.
RVPH vs RUN Fundamental Comparison
| Metric | RVPH | RUN |
|---|---|---|
| Revenue | $122,867.0 | $3.0B |
| Net Income | $-19.9M | $449.9M |
| Net Margin | -16,167.8% | 15.2% |
| ROE | -229.7% | 14.4% |
| ROA | -124.8% | 2.0% |
| Current Ratio | 2.08x | 1.66x |
| Debt/Equity | 0.00x | 4.69x |
| EPS | N/A | $1.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVPH vs RUN: Frequently Asked Questions
Is RVPH or RUN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RUN has stronger fundamentals. RVPH is rated STRONG SELL (90% confidence) while RUN is rated HOLD (65% confidence). This is not investment advice.
How does RVPH compare to RUN fundamentally?
REVIVA PHARMACEUTICALS HOLDINGS, INC. has ROE of -229.7% vs Sunrun Inc.'s 14.4%. Net margins are -16,167.8% vs 15.2% respectively.
Which stock pays higher dividends, RVPH or RUN?
RVPH has a dividend yield of N/A or no dividend while RUN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVPH or RUN for long term?
For long-term investing, consider that RVPH has STRONG SELL rating with 90% confidence, while RUN has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVPH vs RUN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVPH vs RUN, the AI consensus favors RUN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.